Repare Therapeutics

Repare Therapeutics

  • Founded: 2016
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin1/Clin2
  • Therapy area: Solid tumors
  • Drug types: ONC
  • Lead product: Camonsertib (partner: Roche)
  • Product link: https://www.reparerx.com/pipeline/
  • Funding: $253M IPO Jun 2020; $82.5M B Sep 2019; $68M A Jun 2017


reparerx.com

linkedin.com

job board


Short description:

Synthetic Lethal Therapeutics

Drug notes:

Also 3 additional trials Clin1/Clin2 solid tumors; RP-6306 3 trials Clin1/Clin2 solid tumors; 4 undisclosed programs RD/Clin0 oncology, undisclosed

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com